बेनि सोलाय बांसिन बिबांनि एदावग्रा बेरामखौ मोननो केन्सार बेरेखा साइक्ल’पसपामाइडनि राहाखौ बाहायो।
Instead, higher response rates are achieved with the aggressive, cyclophosphamide-based regimens that are used for non-Hodgkin's lymphoma.